IMRIS (OTCMKTS:IMRSQ) and Electromed (NYSE:ELMD) Financial Review

IMRIS (OTCMKTS:IMRSQ) and Electromed (NYSE:ELMD) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, dividends, risk, analyst recommendations, institutional ownership, valuation and earnings.

Analyst Ratings

This is a breakdown of current recommendations and price targets for IMRIS and Electromed, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IMRIS	0	0	0	0	0.00
Electromed	0	0	0	1	4.00

Electromed has a consensus price target of $38.00, suggesting a potential upside of 35.86%. Given Electromed’s stronger consensus rating and higher probable upside, analysts clearly believe Electromed is more favorable than IMRIS.

Earnings & Valuation

This table compares IMRIS and Electromed”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IMRIS	N/A	N/A	N/A	N/A	N/A
Electromed	$59.63 million	4.01	$5.15 million	$0.75	37.29

Electromed has higher revenue and earnings than IMRIS.

Profitability

This table compares IMRIS and Electromed’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
IMRIS	N/A	N/A	N/A
Electromed	11.34%	15.71%	13.37%

Insider and Institutional Ownership

40.8% of Electromed shares are owned by institutional investors. 14.0% of Electromed shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Electromed beats IMRIS on 9 of the 9 factors compared between the two stocks.

About IMRIS

IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.

About Electromed

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.